Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review

被引:10
|
作者
Lou, Tianwen [1 ,2 ]
Tao, Borui [1 ,2 ]
Chen, Ming [2 ]
机构
[1] Anhui Med Univ, Clin Med Coll 1, Hefei, Peoples R China
[2] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei, Peoples R China
关键词
Apolipoprotein E; Alzheimer?s disease; Ab pathology; cerebral amyloid angiopathy; neurodegenerative disease; Major depressive disorder; TRAUMATIC BRAIN-INJURY; INCIDENT DEPRESSIVE SYMPTOMS; CEREBRAL AMYLOID ANGIOPATHY; DIABETES-MELLITUS; GENE POLYMORPHISM; APOE EPSILON-4; BETA; TAU; METAANALYSIS; BURDEN;
D O I
10.1016/j.neuroscience.2023.01.032
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) and other neurodegenerative diseases, for which there is no effective cure, cause great social burden. Apolipoprotein E (APOE) is an important lipid transporter, which has been shown to have a close relationship with AD and other neurological disorders in an increasing number of studies, sug-gesting its potential as a therapeutic target. In this review, we summarize the recent advances in clinical and basic research on the role of APOE in the pathogenesis of multiple neurological diseases, with an emphasis on the new associations between APOE and AD, and between APOE and depression. The progress of APOE research in Parkinson's disease (PD) and some other neurological diseases is briefly discussed.(c) 2023 IBRO. Published by Else-vier Ltd. All rights reserved.
引用
收藏
页码:123 / 140
页数:18
相关论文
共 50 条
  • [21] Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer's disease and other disorders
    Itzhaki, RF
    Wozniak, MA
    PROGRESS IN LIPID RESEARCH, 2006, 45 (01) : 73 - 90
  • [22] Apolipoprotein E and survival in Alzheimer's disease
    Rocca, WA
    Waring, SC
    Tangalos, EG
    Kokmen, E
    Petersen, RC
    NEUROLOGY, 1996, 46 (02) : 55003 - 55003
  • [23] Apolipoprotein E genotyping in Alzheimer's disease
    Relkin, NR
    Tanzi, R
    Breitner, J
    Farrer, L
    Gandy, S
    Haines, J
    Hyman, B
    Mullan, M
    Poirer, J
    Strittmatter, W
    Folstein, M
    Farlow, M
    Mayeux, R
    Petersen, R
    Roses, A
    Schenk, D
    Small, G
    VanGool, W
    CookDeegan, R
    Fleck, L
    Kapp, M
    Karlinsky, H
    PericakVance, M
    Post, S
    Wolpert, C
    Berg, L
    Blass, J
    Fletcher, J
    Hegele, R
    Khachaturian, Z
    Selkoe, D
    Thal, L
    Whitehouse, P
    Kwon, YG
    LANCET, 1996, 347 (9008): : 1091 - 1095
  • [24] The Role of Apolipoprotein E in Alzheimer's Disease
    Kim, Jungsu
    Basak, Jacob M.
    Holtzman, David M.
    NEURON, 2009, 63 (03) : 287 - 303
  • [25] Alzheimer's disease and apolipoprotein E in Italy
    Sorbi, S
    Nacmias, B
    Forleo, P
    Piacentini, S
    Amaducci, L
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 260 - 265
  • [26] Role of apolipoprotein E in Alzheimer's disease
    Zannis, VI
    Zanni, EE
    Makrides, SC
    Kardassis, D
    Aleshkov, S
    VASCULAR ENDOTHELIUM: PHARMACOLOGIC AND GENETIC MANIPULATIONS, 1998, 294 : 179 - 209
  • [27] Apolipoprotein E and the cost of Alzheimer's disease
    Frisoni, GB
    Bianchetti, A
    Trabucchi, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1997, 12 (05) : 588 - 589
  • [28] Impact of Apolipoprotein E on Alzheimer's Disease
    Hauser, Paul S.
    Ryan, Robert O.
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (08) : 809 - 817
  • [29] Apolipoprotein E, cholesterol and Alzheimer's disease
    Burns, M
    Olm, V
    Duff, K
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S401 - S401
  • [30] Apolipoprotein E in Alzheimer's Disease: An Update
    Yu, Jin-Tai
    Tan, Lan
    Hardy, John
    ANNUAL REVIEW OF NEUROSCIENCE, VOL 37, 2014, 37 : 79 - 100